Historique
Rapport
Residential treatment for drug use in Europe
Auteur(s) :
OEDT = EMCDDA (Observatoire européen des drogues et des dépendances = European monitoring centre for drugs and drug addiction) ;
GROSHKOVA, T. ;
HEDRICH, D. ;
FERRI, M. ;
MONTANARI, L.
Année
2014
Page(s) :
31 p.
Langue(s) :
Anglais
Collection :
EMCDDA Papers
ISBN :
978-92-9168-742-8
Domaine :
Drogues illicites / Illicit drugs
Thésaurus géographique
EUROPE
Organismes
OEDT
Thésaurus mots-clés
TRAITEMENT RESIDENTIEL
;
DISPOSITIF DE SOIN
;
ACCES AUX SOINS
;
COMMUNAUTE THERAPEUTIQUE
;
TRAITEMENT
;
PROGRAMME
Note de contenu :
TABLE OF CONTENTS:
Summary
Introduction
Historical perspective of residential treatment for drug users
Extent and nature of residential treatment
Treatment elements in residential programmes
Residential treatment clients
Organisational structure of residential treatment
Conclusions
Summary
Introduction
Historical perspective of residential treatment for drug users
Extent and nature of residential treatment
Treatment elements in residential programmes
Residential treatment clients
Organisational structure of residential treatment
Conclusions
Résumé :
Today, in most European countries, residential treatment programmes form an important element of the range of treatment and rehabilitation options for drug users. The aim of this paper is to provide a Europe-wide overview of the history and availability of residential drug treatment within wider national drug treatment systems. To help with this, the paper describes the history and availability of residential treatment in Europe and develops a categorisation of the broad range of available models and treatment approaches applied in residential settings. Countries differ in the level of residential treatment provision. Over two-thirds of the 2 500 reported facilities in Europe are concentrated in just six countries, each reporting over 100 facilities. A description is provided of the characteristics of residential treatment (inpatient) clients, as well as discussion of organisational and quality assurance issues relevant to residential treatment and how these matters are dealt with across Europe.